Study in Healthy Subjects to Compare the Concentrations of the Omega-3 Fatty Acids EPA and DHA in Blood When Delivered as Three New Capsules in Relation to the Epanova® Capsule Under Fasting and Fed Conditions

PHASE1CompletedINTERVENTIONAL

Enrollment

137

Participants

Timeline

Start Date

February 12, 2015

Primary Completion Date

July 27, 2015

Study Completion Date

July 27, 2015

Conditions

Relative BioavailabilityAUCCmaxPharmacokinetics

Interventions

DRUG

D1400147

Treatment A

DRUG

D14000136

Treatment B

DRUG

D14000137

Treatment C

DRUG

Epanova®

Treatment D

Trial Locations (1)

Research Site, Baltimore